|
2020 Conference Publication Sitagliptin improves clinical outcomes in cystic fibrosis impaired glucose toleranceKeating, R. and Burr, L. (2020). Sitagliptin improves clinical outcomes in cystic fibrosis impaired glucose tolerance. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC, Australia, 27-31 March 2020. Richmond, VIC Australia: John Wiley & Sons. |
|
2020 Conference Publication Carriage and transmission of macrolide resistance genes in patients with chronic lung diseasesWang, Y., Taylor, S., Basham, J., Keating, R., Hindmarsh, K., Choo, J., Wesselingh, S., Burr, L. and Rogers, G. (2020). Carriage and transmission of macrolide resistance genes in patients with chronic lung diseases. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science TSANZSRS 2020, Melbourne, VIC Australia, 27-31 March 2020. Richmond, VIC Australia: John Wiley & Sons. |
|
2020 Journal Article Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasisRamsey, Kathryn A., Chen, Alice C. H., Radicioni, Giorgia, Lourie, Rohan, Martin, Megan, Broomfield, Amy, Sheng, Yong H., Hasnain, Sumaira Z., Radford-Smith, Graham, Simms, Lisa A., Burr, Lucy, Thornton, David J., Bowler, Simon D., Livengood, Stephanie, Ceppe, Agathe, Knowles, Michael R., Noone, Peadar G., Donaldson, Scott H., Hill, David B., Ehre, Camille, Button, Brian, Alexis, Neil E., Kesimer, Mehmet, Boucher, Richard C. and McGuckin, Michael A. (2020). Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 201 (6), 661-670. doi: 10.1164/rccm.201906-1219OC |
|
2020 Conference Publication Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infectionHasnain, S., Wang, R., Taylor, S., Wong, K. Y., Moniruzzaman, M., Upham, J., Spann, K., Mcguckin, M. A., Burr, L. and Phipps, S. (2020). Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection. TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne, VIC, Australia, 27–31 March 2020. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13777 |
|
2020 Journal Article Clinical care of pregnant and postpartum women with COVID-19: living recommendations from the National COVID-19 Clinical Evidence TaskforceVogel, Joshua P., Tendal, Britta, Giles, Michelle, Whitehead, Clare, Burton, Wendy, Chakraborty, Samantha, Cheyne, Saskia, Downton, Teena, Fraile Navarro, David, Gleeson, Glenda, Gordon, Adrienne, Hunt, Jenny, Kitschke, Jackie, McDonald, Steven, McDonnell, Nolan, Middleton, Philippa, Millard, Tanya, Murano, Melissa, Oats, Jeremy, Tate, Rhiannon, White, Heath, Elliott, Julian, Roach, Vijay, Homer, Caroline S.E., McGowan, Sharon, Ballenden, Nicola, Barrett, Terri-Lee, Beavis, Vanessa, Saunders, James Beckford ... National COVID-19 Clinical Evidence Taskforce (2020). Clinical care of pregnant and postpartum women with COVID-19: living recommendations from the National COVID-19 Clinical Evidence Taskforce. Australian and New Zealand Journal of Obstetrics and Gynaecology, 60 (6) ajo.13270, 840-851. doi: 10.1111/ajo.13270 |
|
2019 Journal Article Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?Visser, Simone K., Bye, Peter T. P., Fox, Greg J., Burr, Lucy D., Chang, Anne B., Holmes-Liew, Chien-Li, King, Paul, Middleton, Peter G., Maguire, Graeme P., Smith, Daniel, Thomson, Rachel M., Stroil-Salama, Enna, Britton, Warwick J. and Morgan, Lucy C. (2019). Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?. Lung, 197 (6), 803-810. doi: 10.1007/s00408-019-00280-x |
|
2019 Journal Article Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysisChalmers, James D, Boersma, Wim, Lonergan, Mike, Jayaram, Lata, Crichton, Megan L, Karalus, Noel, Taylor, Steven L, Martin, Megan L, Burr, Lucy D, Wong, Conroy and Altenburg, Josje (2019). Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respiratory Medicine, 7 (10), 845-854. doi: 10.1016/s2213-2600(19)30191-2 |
|
2019 Conference Publication Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysisAltenburg, Josje, Chalmers, James, Lonergan, Mike, Jayaram, Lata, Burr, Lucy, Crichton, Megan, Karalus, Noel, Martin, Megan, Taylor, Steven, Wong, Conroy and Boersma, Wim (2019). Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis. International Congress of the European-Respiratory-Society (ERS), Madrid Spain, Sep 28-Oct 02, 2019. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2019.OA4945 |
|
2019 Conference Publication A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosisTong, Koliarne, Dorahy, Douglas, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Barker, Daniel and Wark, Peter (2019). A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis. International Congress of the European-Respiratory-Society (ERS), Madrid Spain, Sep 28-Oct 02, 2019. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2019.OA2126 |
|
2019 Journal Article The impact of CFTR modulator therapies on CF airway microbiologyRogers, Geraint B., Taylor, Steven L., Hoffman, Lucas R. and Burr, Lucy D. (2019). The impact of CFTR modulator therapies on CF airway microbiology. Journal of Cystic Fibrosis, 19 (3), 359-364. doi: 10.1016/j.jcf.2019.07.008 |
|
2019 Journal Article Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registryVisser, Simone K., Bye, Peter T.P., Fox, Greg J., Burr, Lucy D., Chang, Anne B., Holmes-Liew, Chien-Li, King, Paul, Middleton, Peter G., Maguire, Graeme P., Smith, Daniel, Thomson, Rachel M., Stroil-Salama, Enna, Britton, Warwick J. and Morgan, Lucy C. (2019). Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registry. Respiratory Medicine, 155, 97-103. doi: 10.1016/j.rmed.2019.07.016 |
|
2019 Journal Article Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung diseaseTong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006 |
|
2019 Conference Publication Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis PatientsThomson, R., Scoleri, G., Taylor, S., Leong, L., Burr, L. and Rogers, G. (2019). Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis Patients. International Conference of the American-Thoracic-Society, Dallas Tx, May 17-22, 2019. NEW YORK: AMER THORACIC SOC. doi: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1035 |
|
2018 Journal Article Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gutWang, Yanan, Leong, Lex E.X., Keating, Rebecca L., Kanno, Tokuwa, Abell, Guy C.J., Mobegi, Fredrick M., Choo, Jocelyn M., Wesselingh, Steve L., Mason, A. James, Burr, Lucy D. and Rogers, Geraint B. (2018). Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut. Gut Microbes, 10 (3), 1-15. doi: 10.1080/19490976.2018.1534512 |
|
2018 Journal Article VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del allelesKeating, Dominic, Marigowda, Gautham, Burr, Lucy, Daines, Cori, Mall, Marcus A., McKone, Edward F., Ramsey, Bonnie W., Rowe, Steven M., Sass, Laura A., Tullis, Elizabeth, McKee, Charlotte M., Moskowitz, Samuel M., Robertson, Sarah, Savage, Jessica, Simard, Christopher, Van Goor, Fredrick, Waltz, David, Xuan, Fengjuan, Young, Tim and Taylor-Cousar, Jennifer L. (2018). VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles. New England Journal of Medicine, 379 (17), 1612-1620. doi: 10.1056/NEJMoa1807120 |
|
2018 Journal Article PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa Burr, Lucy D., Rogers, Geraint B., Chen, Alice C.-H., Taylor, Steven L., Bowler, Simon D., Keating, Rebecca L., Martin, Megan L., Hasnain, Sumaira Z. and McGuckin, Michael A. (2018). PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa . PLoS ONE, 13 (8) e0202296, e0202296. doi: 10.1371/journal.pone.0202296 |
|
2018 Journal Article Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategyTaylor, Steven L., Leong, Lex E. X., Mobegi, Fredrick M., Choo, Jocelyn M., Burr, Lucy D., Wesselingh, Steve and Rogers, Geraint B. (2018). Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy. Multidisciplinary Respiratory Medicine, 13 (S1) 30, 30. doi: 10.1186/s40248-018-0140-9 |
|
2018 Journal Article Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasisChoo, Jocelyn M., Abell, Guy C. J., Thomson, Rachel, Morgan, Lucy, Waterer, Grant, Gordon, David L., Taylor, Steven L., Leong, Lex E. X., Wesselingh, Steve L., Burr, Lucy D. and Rogers, Geraint B. (2018). Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis. mSphere, 3 (2) e00103-18, e00103-18. doi: 10.1128/mSphere.00103-18 |
|
2017 Other Outputs An investigation into the effect of erythromycin on Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasisBurr, Lucy Davina (2017). An investigation into the effect of erythromycin on Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis. PhD Thesis, School of Medicine, The University of Queensland. doi: 10.14264/uql.2017.836 |
|
2017 Conference Publication AUDIT OF PRESCRIBING, MONITORING AND DOSAGE OF TOBRAMYCIN WITHIN A METROPOLITAN CYSTIC FIBROSIS UNITOlive, Gerard and Burr, Lucy (2017). AUDIT OF PRESCRIBING, MONITORING AND DOSAGE OF TOBRAMYCIN WITHIN A METROPOLITAN CYSTIC FIBROSIS UNIT. HOBOKEN: WILEY. |
